Current regulatory and market environment for biosimilars in Serbia

Background: Biosimilars are currently a reality of the pharmaceutical market in the European Union. This paper describes the current regulatory policy for approving biosimilars both in the European Union and in Serbia, which is not a Member State. Also, a comprehensive analysis on biosimilars consum...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Zdravstveno varstvo 2014-03, Vol.53 (1), p.101-114
Hauptverfasser:	Pejovic, Gordana, Filipovic, Jovan
Format:	Artikel
Sprache:	eng
Schlagworte:	agencije za zdravila Biological products biosimilar consumption marketing authorisation medicine regulatory authority Pharmaceuticals podobno biološko zdravilo poraba zdravil registracija zdravil Regulatory agencies Regulatory approval Serbia Srbija
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!